

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neurofilament cytoskeleton organization (GO:0060052) | 8.10550789 |
| 2 | detection of temperature stimulus (GO:0016048) | 7.55238978 |
| 3 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 7.53831037 |
| 4 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 7.53831037 |
| 5 | negative regulation of dendrite morphogenesis (GO:0050774) | 6.85546781 |
| 6 | peripheral nervous system neuron development (GO:0048935) | 6.61737761 |
| 7 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 6.41461442 |
| 8 | neuronal action potential (GO:0019228) | 6.10239893 |
| 9 | cell migration in hindbrain (GO:0021535) | 5.86472676 |
| 10 | response to pain (GO:0048265) | 5.09956053 |
| 11 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 5.06905833 |
| 12 | behavioral response to pain (GO:0048266) | 4.92417658 |
| 13 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 4.84093025 |
| 14 | proline transport (GO:0015824) | 4.70921904 |
| 15 | regulation of female receptivity (GO:0045924) | 4.70559819 |
| 16 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 4.67875276 |
| 17 | response to water (GO:0009415) | 4.66580196 |
| 18 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.63363691 |
| 19 | negative regulation of microtubule polymerization (GO:0031115) | 4.57499659 |
| 20 | membrane depolarization during action potential (GO:0086010) | 4.52904391 |
| 21 | negative regulation of Rho protein signal transduction (GO:0035024) | 4.38150498 |
| 22 | negative regulation of dendrite development (GO:2000171) | 4.28911757 |
| 23 | neuronal action potential propagation (GO:0019227) | 4.16372320 |
| 24 | cell communication involved in cardiac conduction (GO:0086065) | 4.00633433 |
| 25 | intermediate filament organization (GO:0045109) | 3.88137633 |
| 26 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 3.87614978 |
| 27 | protein K11-linked deubiquitination (GO:0035871) | 3.87597523 |
| 28 | enteric nervous system development (GO:0048484) | 3.85074816 |
| 29 | urinary tract smooth muscle contraction (GO:0014848) | 3.81142761 |
| 30 | membrane budding (GO:0006900) | 3.80428375 |
| 31 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.77187356 |
| 32 | axon cargo transport (GO:0008088) | 3.76364239 |
| 33 | female mating behavior (GO:0060180) | 3.72527597 |
| 34 | negative regulation of cation channel activity (GO:2001258) | 3.72083420 |
| 35 | cellular response to nicotine (GO:0071316) | 3.67500943 |
| 36 | establishment of mitochondrion localization (GO:0051654) | 3.63228864 |
| 37 | intermediate filament-based process (GO:0045103) | 3.57236004 |
| 38 | intermediate filament cytoskeleton organization (GO:0045104) | 3.56365994 |
| 39 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.55927777 |
| 40 | action potential (GO:0001508) | 3.55230859 |
| 41 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.54247934 |
| 42 | adenosine metabolic process (GO:0046085) | 3.53044586 |
| 43 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.50258676 |
| 44 | potassium ion export (GO:0071435) | 3.48509467 |
| 45 | plasma membrane repair (GO:0001778) | 3.43864785 |
| 46 | retinal ganglion cell axon guidance (GO:0031290) | 3.42869219 |
| 47 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.35428745 |
| 48 | cellular response to ATP (GO:0071318) | 3.35168435 |
| 49 | regulation of memory T cell differentiation (GO:0043380) | 3.34565542 |
| 50 | neural tube formation (GO:0001841) | 3.32985451 |
| 51 | membrane repolarization (GO:0086009) | 3.28857999 |
| 52 | response to acidic pH (GO:0010447) | 3.27066483 |
| 53 | regulation of platelet aggregation (GO:0090330) | 3.26859043 |
| 54 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.26811225 |
| 55 | mitochondrion transport along microtubule (GO:0047497) | 3.26811225 |
| 56 | neuromuscular synaptic transmission (GO:0007274) | 3.26118580 |
| 57 | response to ATP (GO:0033198) | 3.22538004 |
| 58 | regulation of skeletal muscle contraction (GO:0014819) | 3.22321287 |
| 59 | negative regulation of complement activation (GO:0045916) | 3.21840459 |
| 60 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 3.21614122 |
| 61 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 3.20439666 |
| 62 | positive regulation of muscle hypertrophy (GO:0014742) | 3.20439666 |
| 63 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.19240715 |
| 64 | axon development (GO:0061564) | 3.16073331 |
| 65 | sympathetic nervous system development (GO:0048485) | 3.15749013 |
| 66 | glutamate secretion (GO:0014047) | 3.15006397 |
| 67 | positive regulation of potassium ion transport (GO:0043268) | 3.13294458 |
| 68 | somite development (GO:0061053) | 3.13191365 |
| 69 | sodium ion transmembrane transport (GO:0035725) | 3.12991351 |
| 70 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.12903047 |
| 71 | protein maturation by protein folding (GO:0022417) | 3.07026721 |
| 72 | axoneme assembly (GO:0035082) | 3.05182892 |
| 73 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.04380473 |
| 74 | detection of light stimulus involved in visual perception (GO:0050908) | 3.04380473 |
| 75 | neuron fate specification (GO:0048665) | 3.04258869 |
| 76 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 3.03191132 |
| 77 | synaptic vesicle maturation (GO:0016188) | 3.02913155 |
| 78 | regulation of cell maturation (GO:1903429) | 3.02839725 |
| 79 | innervation (GO:0060384) | 3.02559004 |
| 80 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.02446299 |
| 81 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.01712195 |
| 82 | sodium ion export (GO:0071436) | 2.99838442 |
| 83 | calcium ion-dependent exocytosis (GO:0017156) | 2.97042758 |
| 84 | regulation of translational termination (GO:0006449) | 2.95601827 |
| 85 | behavioral response to nicotine (GO:0035095) | 2.94442372 |
| 86 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.92078265 |
| 87 | sulfation (GO:0051923) | 2.91445896 |
| 88 | regulation of sequestering of triglyceride (GO:0010889) | 2.90773813 |
| 89 | organelle transport along microtubule (GO:0072384) | 2.89427320 |
| 90 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.89187978 |
| 91 | acrosome reaction (GO:0007340) | 2.88518114 |
| 92 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.87611277 |
| 93 | regulation of cell communication by electrical coupling (GO:0010649) | 2.87393603 |
| 94 | negative regulation of mast cell activation (GO:0033004) | 2.86874595 |
| 95 | fucose catabolic process (GO:0019317) | 2.86392665 |
| 96 | L-fucose metabolic process (GO:0042354) | 2.86392665 |
| 97 | L-fucose catabolic process (GO:0042355) | 2.86392665 |
| 98 | phenol-containing compound catabolic process (GO:0019336) | 2.86185076 |
| 99 | alanine transport (GO:0032328) | 2.85015294 |
| 100 | negative regulation of ion transmembrane transporter activity (GO:0032413) | 2.84629821 |
| 101 | vesicle transport along microtubule (GO:0047496) | 2.84575713 |
| 102 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.84241789 |
| 103 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.84236460 |
| 104 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.83261557 |
| 105 | regulation of germinal center formation (GO:0002634) | 2.82716774 |
| 106 | indolalkylamine metabolic process (GO:0006586) | 2.80677150 |
| 107 | histone H3-K4 trimethylation (GO:0080182) | 2.80559984 |
| 108 | multicellular organismal response to stress (GO:0033555) | 2.79605034 |
| 109 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.79097610 |
| 110 | axon regeneration (GO:0031103) | 2.79093859 |
| 111 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.78098301 |
| 112 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.77124161 |
| 113 | regulation of histone phosphorylation (GO:0033127) | 2.75841686 |
| 114 | sensory perception of taste (GO:0050909) | 2.74408850 |
| 115 | positive regulation of fatty acid oxidation (GO:0046321) | 2.74389938 |
| 116 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.74181918 |
| 117 | synaptic vesicle exocytosis (GO:0016079) | 2.72964703 |
| 118 | adaptation of signaling pathway (GO:0023058) | 2.72944650 |
| 119 | response to pheromone (GO:0019236) | 2.72893193 |
| 120 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.70713427 |
| 121 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.69945410 |
| 122 | protein polyglutamylation (GO:0018095) | 2.69285491 |
| 123 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.68959927 |
| 124 | negative regulation of sodium ion transport (GO:0010766) | 2.68800996 |
| 125 | indole-containing compound catabolic process (GO:0042436) | 2.67697938 |
| 126 | indolalkylamine catabolic process (GO:0046218) | 2.67697938 |
| 127 | tryptophan catabolic process (GO:0006569) | 2.67697938 |
| 128 | thrombin receptor signaling pathway (GO:0070493) | 2.67619263 |
| 129 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.66801360 |
| 130 | regulation of sensory perception of pain (GO:0051930) | 2.66150853 |
| 131 | regulation of sensory perception (GO:0051931) | 2.66150853 |
| 132 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.65598298 |
| 133 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 2.64391412 |
| 134 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.64147738 |
| 135 | negative regulation of cell killing (GO:0031342) | 2.64147738 |
| 136 | germinal center formation (GO:0002467) | 2.60396143 |
| 137 | alkaloid metabolic process (GO:0009820) | 2.57807607 |
| 138 | synaptic transmission, cholinergic (GO:0007271) | 2.56937234 |
| 139 | kynurenine metabolic process (GO:0070189) | 2.56812774 |
| 140 | cell wall macromolecule catabolic process (GO:0016998) | 2.55886776 |
| 141 | DNA deamination (GO:0045006) | 2.54003827 |
| 142 | cAMP catabolic process (GO:0006198) | 2.53347438 |
| 143 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.51847581 |
| 144 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.51847581 |
| 145 | transmission of nerve impulse (GO:0019226) | 2.51682488 |
| 146 | epithelial cilium movement (GO:0003351) | 2.50231845 |
| 147 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.49525037 |
| 148 | tachykinin receptor signaling pathway (GO:0007217) | 2.46792265 |
| 149 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.46529493 |
| 150 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.44793100 |
| 151 | establishment of protein localization to Golgi (GO:0072600) | 2.44314678 |
| 152 | head development (GO:0060322) | 2.44200110 |
| 153 | response to lipoprotein particle (GO:0055094) | 2.43049272 |
| 154 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.42374585 |
| 155 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.42163340 |
| 156 | histone H3-K9 methylation (GO:0051567) | 2.41806159 |
| 157 | histone H3-K9 modification (GO:0061647) | 2.41147737 |
| 158 | dentate gyrus development (GO:0021542) | 2.40509443 |
| 159 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.39432760 |
| 160 | oxygen transport (GO:0015671) | 2.37251319 |
| 161 | photoreceptor cell maintenance (GO:0045494) | 2.36454190 |
| 162 | embryonic epithelial tube formation (GO:0001838) | 2.35816413 |
| 163 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.35471251 |
| 164 | activated T cell proliferation (GO:0050798) | 2.34962769 |
| 165 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.32763550 |
| 166 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.32763550 |
| 167 | retinal cone cell development (GO:0046549) | 2.29610838 |
| 168 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.29389552 |
| 169 | snRNA transcription (GO:0009301) | 2.28718579 |
| 170 | thyroid hormone metabolic process (GO:0042403) | 2.28651678 |
| 171 | neutrophil mediated immunity (GO:0002446) | 2.28580966 |
| 172 | cyclic nucleotide catabolic process (GO:0009214) | 2.27860259 |
| 173 | drug catabolic process (GO:0042737) | 2.27821734 |
| 174 | negative regulation of response to food (GO:0032096) | 2.27719941 |
| 175 | negative regulation of appetite (GO:0032099) | 2.27719941 |
| 176 | protein K48-linked deubiquitination (GO:0071108) | 2.27690768 |
| 177 | negative regulation by host of viral transcription (GO:0043922) | 2.27053268 |
| 178 | long term synaptic depression (GO:0060292) | 2.26927593 |
| 179 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.26046698 |
| 180 | regulation of action potential (GO:0098900) | 2.23350612 |
| 181 | cilium movement (GO:0003341) | 2.22760017 |
| 182 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.22537853 |
| 183 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 2.21542282 |
| 184 | myeloid leukocyte mediated immunity (GO:0002444) | 2.20757250 |
| 185 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.19983882 |
| 186 | phosphatidylethanolamine metabolic process (GO:0046337) | 2.19920233 |
| 187 | negative regulation of cell cycle arrest (GO:0071157) | 2.19756893 |
| 188 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.19250733 |
| 189 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.19234203 |
| 190 | striated muscle atrophy (GO:0014891) | 2.19049539 |
| 191 | nonmotile primary cilium assembly (GO:0035058) | 2.18380809 |
| 192 | protein K63-linked deubiquitination (GO:0070536) | 2.15627431 |
| 193 | oxidative demethylation (GO:0070989) | 2.15179062 |
| 194 | positive regulation of defense response to virus by host (GO:0002230) | 2.14656673 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.98048777 |
| 2 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.94113154 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.61171902 |
| 4 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 2.59093707 |
| 5 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.57763747 |
| 6 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.44258790 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.40114748 |
| 8 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.25047325 |
| 9 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.21406411 |
| 10 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.20833503 |
| 11 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.19974481 |
| 12 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.17082070 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.16289472 |
| 14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.12959648 |
| 15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.12959648 |
| 16 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.99877663 |
| 17 | VDR_22108803_ChIP-Seq_LS180_Human | 1.99529020 |
| 18 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.92515171 |
| 19 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.89727927 |
| 20 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.87255680 |
| 21 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.87255281 |
| 22 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.81629344 |
| 23 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.79368481 |
| 24 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.78936898 |
| 25 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.77631975 |
| 26 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.75826161 |
| 27 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.74672901 |
| 28 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.74672573 |
| 29 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.71427729 |
| 30 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.70738787 |
| 31 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.69405776 |
| 32 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.67881743 |
| 33 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.66253328 |
| 34 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.63774163 |
| 35 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.61811487 |
| 36 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.59651960 |
| 37 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.58920362 |
| 38 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.58258672 |
| 39 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.55049658 |
| 40 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.54362704 |
| 41 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.54158908 |
| 42 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.52434845 |
| 43 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.51983220 |
| 44 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.51225891 |
| 45 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.48852577 |
| 46 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.48322706 |
| 47 | KDM2B_26808549_Chip-Seq_K562_Human | 1.46563673 |
| 48 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.46200237 |
| 49 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.45940607 |
| 50 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.45478017 |
| 51 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.45368383 |
| 52 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.44604590 |
| 53 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.44604590 |
| 54 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.44031782 |
| 55 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.43992223 |
| 56 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.43781420 |
| 57 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.41295145 |
| 58 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.40483176 |
| 59 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.39895348 |
| 60 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.38378076 |
| 61 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.37498741 |
| 62 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.37363605 |
| 63 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.35130750 |
| 64 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.34998897 |
| 65 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.34163659 |
| 66 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.31251226 |
| 67 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.30894113 |
| 68 | FUS_26573619_Chip-Seq_HEK293_Human | 1.29326299 |
| 69 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.28215855 |
| 70 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.27855628 |
| 71 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.27601299 |
| 72 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25826977 |
| 73 | TCF4_23295773_ChIP-Seq_U87_Human | 1.25549048 |
| 74 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.24752297 |
| 75 | TP53_16413492_ChIP-PET_HCT116_Human | 1.22252099 |
| 76 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.20794158 |
| 77 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.20166585 |
| 78 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.19704582 |
| 79 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.19536715 |
| 80 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.19101598 |
| 81 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.19021316 |
| 82 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.18921676 |
| 83 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.18883343 |
| 84 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.17336430 |
| 85 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.17314114 |
| 86 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.14080887 |
| 87 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.13153845 |
| 88 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.12923874 |
| 89 | * TP53_22573176_ChIP-Seq_HFKS_Human | 1.11965792 |
| 90 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.11956555 |
| 91 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11289045 |
| 92 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10689521 |
| 93 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.10105843 |
| 94 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.10104194 |
| 95 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.09811152 |
| 96 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.09680390 |
| 97 | P300_19829295_ChIP-Seq_ESCs_Human | 1.09485574 |
| 98 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.09283903 |
| 99 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.08755705 |
| 100 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.08702047 |
| 101 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.08387606 |
| 102 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.08293487 |
| 103 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.08280806 |
| 104 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.07816307 |
| 105 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.06912551 |
| 106 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.06839313 |
| 107 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.06440636 |
| 108 | AR_25329375_ChIP-Seq_VCAP_Human | 1.06157858 |
| 109 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.05040500 |
| 110 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.04141429 |
| 111 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03775423 |
| 112 | EWS_26573619_Chip-Seq_HEK293_Human | 1.03310464 |
| 113 | CJUN_26792858_Chip-Seq_BT549_Human | 1.02619849 |
| 114 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.02572317 |
| 115 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.02362925 |
| 116 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.01951576 |
| 117 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.01527868 |
| 118 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.01527868 |
| 119 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.01246202 |
| 120 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.99698206 |
| 121 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.99661230 |
| 122 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.98647967 |
| 123 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97873844 |
| 124 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.97379864 |
| 125 | NCOR_22424771_ChIP-Seq_293T_Human | 0.96733776 |
| 126 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.96730210 |
| 127 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.96706277 |
| 128 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.96459355 |
| 129 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.95716518 |
| 130 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.95697829 |
| 131 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.95520057 |
| 132 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.95136455 |
| 133 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.95136455 |
| 134 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95029550 |
| 135 | TBL1_22424771_ChIP-Seq_293T_Human | 0.93810532 |
| 136 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.93614499 |
| 137 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.93430946 |
| 138 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.93319587 |
| 139 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.92397427 |
| 140 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.91647525 |
| 141 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.90667881 |
| 142 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.90307712 |
| 143 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.90231910 |
| 144 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.90192023 |
| 145 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.90078268 |
| 146 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.89940151 |
| 147 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.89426722 |
| 148 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.89397003 |
| 149 | STAT3_23295773_ChIP-Seq_U87_Human | 0.89038918 |
| 150 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.88894187 |
| 151 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.88654317 |
| 152 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88304898 |
| 153 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.88031405 |
| 154 | JUN_21703547_ChIP-Seq_K562_Human | 0.87862869 |
| 155 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.87671001 |
| 156 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.87276195 |
| 157 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.86059807 |
| 158 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.85671425 |
| 159 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.85643430 |
| 160 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.85406247 |
| 161 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.85364458 |
| 162 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84781445 |
| 163 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.84333154 |
| 164 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.84105138 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002735_abnormal_chemical_nociception | 7.75712649 |
| 2 | MP0001968_abnormal_touch/_nociception | 6.67470174 |
| 3 | MP0001986_abnormal_taste_sensitivity | 6.13471320 |
| 4 | MP0002736_abnormal_nociception_after | 5.93891146 |
| 5 | MP0004270_analgesia | 4.79091664 |
| 6 | MP0002733_abnormal_thermal_nociception | 4.59805987 |
| 7 | MP0002734_abnormal_mechanical_nocicepti | 4.17115245 |
| 8 | MP0006276_abnormal_autonomic_nervous | 4.10258604 |
| 9 | MP0003787_abnormal_imprinting | 4.01350846 |
| 10 | MP0001970_abnormal_pain_threshold | 3.79876347 |
| 11 | MP0005645_abnormal_hypothalamus_physiol | 3.65087052 |
| 12 | MP0003646_muscle_fatigue | 3.53798880 |
| 13 | MP0003724_increased_susceptibility_to | 3.25614308 |
| 14 | MP0003195_calcinosis | 3.04137252 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.49337740 |
| 16 | MP0002751_abnormal_autonomic_nervous | 2.45859718 |
| 17 | MP0002653_abnormal_ependyma_morphology | 2.42583336 |
| 18 | MP0001485_abnormal_pinna_reflex | 2.35510448 |
| 19 | MP0004130_abnormal_muscle_cell | 2.33284034 |
| 20 | * MP0004858_abnormal_nervous_system | 2.32119441 |
| 21 | MP0000569_abnormal_digit_pigmentation | 2.24921327 |
| 22 | MP0004859_abnormal_synaptic_plasticity | 2.10345449 |
| 23 | MP0000631_abnormal_neuroendocrine_gland | 2.02547577 |
| 24 | MP0008877_abnormal_DNA_methylation | 1.99257167 |
| 25 | MP0005670_abnormal_white_adipose | 1.96667477 |
| 26 | MP0005551_abnormal_eye_electrophysiolog | 1.93642588 |
| 27 | MP0002184_abnormal_innervation | 1.93421205 |
| 28 | MP0002272_abnormal_nervous_system | 1.91903787 |
| 29 | MP0004885_abnormal_endolymph | 1.85400546 |
| 30 | MP0004043_abnormal_pH_regulation | 1.83962488 |
| 31 | MP0002067_abnormal_sensory_capabilities | 1.82725183 |
| 32 | MP0003329_amyloid_beta_deposits | 1.77673905 |
| 33 | MP0002822_catalepsy | 1.71590338 |
| 34 | MP0000372_irregular_coat_pigmentation | 1.66815039 |
| 35 | MP0005083_abnormal_biliary_tract | 1.65667112 |
| 36 | MP0002102_abnormal_ear_morphology | 1.65548340 |
| 37 | MP0005646_abnormal_pituitary_gland | 1.64068448 |
| 38 | MP0003656_abnormal_erythrocyte_physiolo | 1.63768851 |
| 39 | MP0001348_abnormal_lacrimal_gland | 1.61684168 |
| 40 | MP0002876_abnormal_thyroid_physiology | 1.60111209 |
| 41 | MP0004381_abnormal_hair_follicle | 1.56969661 |
| 42 | MP0005174_abnormal_tail_pigmentation | 1.55607718 |
| 43 | MP0008260_abnormal_autophagy | 1.51213290 |
| 44 | MP0001270_distended_abdomen | 1.49664563 |
| 45 | MP0003878_abnormal_ear_physiology | 1.42081139 |
| 46 | MP0005377_hearing/vestibular/ear_phenot | 1.42081139 |
| 47 | MP0003635_abnormal_synaptic_transmissio | 1.38426120 |
| 48 | * MP0004811_abnormal_neuron_physiology | 1.35189130 |
| 49 | MP0000538_abnormal_urinary_bladder | 1.35002879 |
| 50 | MP0003183_abnormal_peptide_metabolism | 1.34539171 |
| 51 | MP0000955_abnormal_spinal_cord | 1.32151309 |
| 52 | MP0005310_abnormal_salivary_gland | 1.31262747 |
| 53 | MP0008004_abnormal_stomach_pH | 1.28276842 |
| 54 | MP0002277_abnormal_respiratory_mucosa | 1.28250410 |
| 55 | MP0001440_abnormal_grooming_behavior | 1.25630232 |
| 56 | MP0003121_genomic_imprinting | 1.20843282 |
| 57 | MP0000230_abnormal_systemic_arterial | 1.18897483 |
| 58 | MP0009745_abnormal_behavioral_response | 1.17046788 |
| 59 | MP0005367_renal/urinary_system_phenotyp | 1.15963978 |
| 60 | MP0000516_abnormal_urinary_system | 1.15963978 |
| 61 | MP0000749_muscle_degeneration | 1.14225729 |
| 62 | MP0010386_abnormal_urinary_bladder | 1.12531779 |
| 63 | MP0002837_dystrophic_cardiac_calcinosis | 1.11484083 |
| 64 | MP0002064_seizures | 1.10301669 |
| 65 | MP0004147_increased_porphyrin_level | 1.09581424 |
| 66 | MP0009046_muscle_twitch | 1.06750047 |
| 67 | MP0001664_abnormal_digestion | 1.06541719 |
| 68 | MP0001800_abnormal_humoral_immune | 1.05346379 |
| 69 | MP0002928_abnormal_bile_duct | 1.04120693 |
| 70 | MP0005167_abnormal_blood-brain_barrier | 1.04095033 |
| 71 | MP0002063_abnormal_learning/memory/cond | 1.02189771 |
| 72 | MP0000604_amyloidosis | 1.01550577 |
| 73 | MP0005253_abnormal_eye_physiology | 1.01043863 |
| 74 | MP0009764_decreased_sensitivity_to | 1.00260199 |
| 75 | MP0000751_myopathy | 0.98448094 |
| 76 | MP0000026_abnormal_inner_ear | 0.98298273 |
| 77 | MP0002572_abnormal_emotion/affect_behav | 0.97621874 |
| 78 | MP0008875_abnormal_xenobiotic_pharmacok | 0.94618213 |
| 79 | MP0005075_abnormal_melanosome_morpholog | 0.93478180 |
| 80 | MP0008872_abnormal_physiological_respon | 0.93351895 |
| 81 | MP0001486_abnormal_startle_reflex | 0.91390727 |
| 82 | MP0003633_abnormal_nervous_system | 0.91351489 |
| 83 | MP0000015_abnormal_ear_pigmentation | 0.90442092 |
| 84 | MP0001905_abnormal_dopamine_level | 0.88507771 |
| 85 | MP0009765_abnormal_xenobiotic_induced | 0.87480569 |
| 86 | MP0002332_abnormal_exercise_endurance | 0.87203995 |
| 87 | MP0001299_abnormal_eye_distance/ | 0.87143918 |
| 88 | * MP0002882_abnormal_neuron_morphology | 0.86740316 |
| 89 | MP0003880_abnormal_central_pattern | 0.86608210 |
| 90 | MP0000747_muscle_weakness | 0.85157862 |
| 91 | MP0002909_abnormal_adrenal_gland | 0.84704612 |
| 92 | MP0000013_abnormal_adipose_tissue | 0.84546421 |
| 93 | MP0002163_abnormal_gland_morphology | 0.84245967 |
| 94 | MP0008569_lethality_at_weaning | 0.83953504 |
| 95 | MP0001963_abnormal_hearing_physiology | 0.83834219 |
| 96 | MP0002148_abnormal_hypersensitivity_rea | 0.82658399 |
| 97 | MP0004924_abnormal_behavior | 0.81279370 |
| 98 | MP0005386_behavior/neurological_phenoty | 0.81279370 |
| 99 | MP0008874_decreased_physiological_sensi | 0.81026234 |
| 100 | MP0003868_abnormal_feces_composition | 0.81022175 |
| 101 | MP0005620_abnormal_muscle_contractility | 0.79672112 |
| 102 | MP0003045_fibrosis | 0.79178733 |
| 103 | MP0000427_abnormal_hair_cycle | 0.78717884 |
| 104 | MP0000685_abnormal_immune_system | 0.78414970 |
| 105 | MP0001765_abnormal_ion_homeostasis | 0.78242513 |
| 106 | MP0004883_abnormal_blood_vessel | 0.78007954 |
| 107 | MP0010771_integument_phenotype | 0.77747351 |
| 108 | MP0003011_delayed_dark_adaptation | 0.77435229 |
| 109 | MP0000049_abnormal_middle_ear | 0.74767580 |
| 110 | MP0005387_immune_system_phenotype | 0.74630483 |
| 111 | MP0001790_abnormal_immune_system | 0.74630483 |
| 112 | MP0002132_abnormal_respiratory_system | 0.74154519 |
| 113 | MP0001984_abnormal_olfaction | 0.73722700 |
| 114 | MP0000534_abnormal_ureter_morphology | 0.72980284 |
| 115 | MP0003866_abnormal_defecation | 0.72559749 |
| 116 | MP0010234_abnormal_vibrissa_follicle | 0.71915902 |
| 117 | MP0009785_altered_susceptibility_to | 0.71570451 |
| 118 | MP0002723_abnormal_immune_serum | 0.70981115 |
| 119 | MP0003631_nervous_system_phenotype | 0.70187501 |
| 120 | MP0000778_abnormal_nervous_system | 0.69961357 |
| 121 | MP0005195_abnormal_posterior_eye | 0.69623568 |
| 122 | MP0005423_abnormal_somatic_nervous | 0.69490576 |
| 123 | MP0001835_abnormal_antigen_presentation | 0.69347506 |
| 124 | MP0003634_abnormal_glial_cell | 0.69196008 |
| 125 | MP0005220_abnormal_exocrine_pancreas | 0.68668985 |
| 126 | MP0001501_abnormal_sleep_pattern | 0.67183653 |
| 127 | MP0002638_abnormal_pupillary_reflex | 0.66684892 |
| 128 | MP0008775_abnormal_heart_ventricle | 0.66433105 |
| 129 | * MP0002229_neurodegeneration | 0.66238518 |
| 130 | * MP0002066_abnormal_motor_capabilities/c | 0.65320291 |
| 131 | MP0002108_abnormal_muscle_morphology | 0.64799650 |
| 132 | MP0003136_yellow_coat_color | 0.63543078 |
| 133 | MP0002452_abnormal_antigen_presenting | 0.63534617 |
| 134 | MP0002168_other_aberrant_phenotype | 0.63527538 |
| 135 | MP0002419_abnormal_innate_immunity | 0.62423233 |
| 136 | MP0004742_abnormal_vestibular_system | 0.61341214 |
| 137 | MP0004142_abnormal_muscle_tone | 0.58634172 |
| 138 | * MP0002752_abnormal_somatic_nervous | 0.57652959 |
| 139 | MP0002160_abnormal_reproductive_system | 0.55190810 |
| 140 | MP0005165_increased_susceptibility_to | 0.53730666 |
| 141 | MP0004085_abnormal_heartbeat | 0.53252714 |
| 142 | MP0003806_abnormal_nucleotide_metabolis | 0.53112917 |
| 143 | MP0003879_abnormal_hair_cell | 0.53096767 |
| 144 | MP0001873_stomach_inflammation | 0.52620695 |
| 145 | MP0004484_altered_response_of | 0.51559702 |
| 146 | MP0004036_abnormal_muscle_relaxation | 0.51361452 |
| 147 | MP0001542_abnormal_bone_strength | 0.48938115 |
| 148 | MP0002557_abnormal_social/conspecific_i | 0.48862964 |
| 149 | MP0001756_abnormal_urination | 0.48651942 |
| 150 | MP0002972_abnormal_cardiac_muscle | 0.47445662 |
| 151 | MP0003300_gastrointestinal_ulcer | 0.44893659 |
| 152 | MP0000920_abnormal_myelination | 0.44086196 |
| 153 | MP0009379_abnormal_foot_pigmentation | 0.43327441 |
| 154 | MP0005535_abnormal_body_temperature | 0.43195648 |
| 155 | MP0001663_abnormal_digestive_system | 0.41648121 |
| 156 | MP0004145_abnormal_muscle_electrophysio | 0.40951530 |
| 157 | MP0009780_abnormal_chondrocyte_physiolo | 0.39226796 |
| 158 | MP0003566_abnormal_cell_adhesion | 0.37097353 |
| 159 | MP0001849_ear_inflammation | 0.34797618 |
| 160 | MP0000759_abnormal_skeletal_muscle | 0.34597750 |
| 161 | MP0005623_abnormal_meninges_morphology | 0.33406807 |
| 162 | MP0002269_muscular_atrophy | 0.32822094 |
| 163 | MP0001943_abnormal_respiration | 0.32719513 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ulnar claw (HP:0001178) | 9.35892631 |
| 2 | Myokymia (HP:0002411) | 6.03485219 |
| 3 | Segmental peripheral demyelination/remyelination (HP:0003481) | 5.91127364 |
| 4 | Termporal pattern (HP:0011008) | 5.81129973 |
| 5 | Insidious onset (HP:0003587) | 5.81129973 |
| 6 | Hypothermia (HP:0002045) | 5.76033515 |
| 7 | Action tremor (HP:0002345) | 5.22799548 |
| 8 | Pheochromocytoma (HP:0002666) | 5.01855112 |
| 9 | Impaired pain sensation (HP:0007328) | 4.84264913 |
| 10 | Abnormality of pain sensation (HP:0010832) | 4.84264913 |
| 11 | Dysautonomia (HP:0002459) | 4.81766198 |
| 12 | Neuroendocrine neoplasm (HP:0100634) | 4.64580391 |
| 13 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 4.28946956 |
| 14 | Steppage gait (HP:0003376) | 4.26067545 |
| 15 | Foot dorsiflexor weakness (HP:0009027) | 4.25893735 |
| 16 | Congenital stationary night blindness (HP:0007642) | 4.19018872 |
| 17 | Hammertoe (HP:0001765) | 4.07939599 |
| 18 | Abnormal autonomic nervous system physiology (HP:0012332) | 3.89155967 |
| 19 | Abnormality of the foot musculature (HP:0001436) | 3.77246098 |
| 20 | Pancreatic cysts (HP:0001737) | 3.75952062 |
| 21 | Distal arthrogryposis (HP:0005684) | 3.64429804 |
| 22 | True hermaphroditism (HP:0010459) | 3.62453331 |
| 23 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 3.62426084 |
| 24 | Short 1st metacarpal (HP:0010034) | 3.57861503 |
| 25 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 3.57861503 |
| 26 | Myotonia (HP:0002486) | 3.57517686 |
| 27 | Pancreatic fibrosis (HP:0100732) | 3.52237703 |
| 28 | Abnormality of midbrain morphology (HP:0002418) | 3.47336000 |
| 29 | Molar tooth sign on MRI (HP:0002419) | 3.47336000 |
| 30 | Onion bulb formation (HP:0003383) | 3.44223395 |
| 31 | Abnormality of the vocal cords (HP:0008777) | 3.37339387 |
| 32 | Hyporeflexia of lower limbs (HP:0002600) | 3.32683535 |
| 33 | Chronic hepatic failure (HP:0100626) | 3.32518151 |
| 34 | Hypercortisolism (HP:0001578) | 3.31158801 |
| 35 | Absent/shortened dynein arms (HP:0200106) | 3.27290290 |
| 36 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.27290290 |
| 37 | Autoamputation (HP:0001218) | 3.27262060 |
| 38 | Nephronophthisis (HP:0000090) | 3.19685040 |
| 39 | Failure to thrive in infancy (HP:0001531) | 3.16678490 |
| 40 | Atonic seizures (HP:0010819) | 3.13077550 |
| 41 | Decreased motor nerve conduction velocity (HP:0003431) | 3.11081443 |
| 42 | Distal sensory impairment (HP:0002936) | 3.10454146 |
| 43 | Abnormality of the 1st metacarpal (HP:0010009) | 3.09496078 |
| 44 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.08643905 |
| 45 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.04911451 |
| 46 | Neoplasm of the peripheral nervous system (HP:0100007) | 3.04575024 |
| 47 | Keratoconjunctivitis (HP:0001096) | 3.03334437 |
| 48 | Supranuclear gaze palsy (HP:0000605) | 2.94991095 |
| 49 | Attenuation of retinal blood vessels (HP:0007843) | 2.93858427 |
| 50 | Thoracolumbar scoliosis (HP:0002944) | 2.92039137 |
| 51 | Bradycardia (HP:0001662) | 2.91230396 |
| 52 | Focal seizures (HP:0007359) | 2.89183985 |
| 53 | Keratoconjunctivitis sicca (HP:0001097) | 2.88446052 |
| 54 | Thyroid carcinoma (HP:0002890) | 2.86152916 |
| 55 | Ankle clonus (HP:0011448) | 2.83422463 |
| 56 | Abnormality of the renal medulla (HP:0100957) | 2.80602011 |
| 57 | Postural tremor (HP:0002174) | 2.78415380 |
| 58 | Orthostatic hypotension (HP:0001278) | 2.78345776 |
| 59 | Febrile seizures (HP:0002373) | 2.70710928 |
| 60 | Congenital sensorineural hearing impairment (HP:0008527) | 2.67595588 |
| 61 | Abnormality of the renal cortex (HP:0011035) | 2.65700662 |
| 62 | Hypoventilation (HP:0002791) | 2.65180232 |
| 63 | Submucous cleft hard palate (HP:0000176) | 2.64581227 |
| 64 | Progressive cerebellar ataxia (HP:0002073) | 2.64112333 |
| 65 | Impaired proprioception (HP:0010831) | 2.62358267 |
| 66 | Ectopic kidney (HP:0000086) | 2.62282733 |
| 67 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.60150829 |
| 68 | Hypoplasia of the brainstem (HP:0002365) | 2.60150829 |
| 69 | Abnormality of the corticospinal tract (HP:0002492) | 2.57365952 |
| 70 | Stomatitis (HP:0010280) | 2.55890081 |
| 71 | Distal lower limb muscle weakness (HP:0009053) | 2.55730263 |
| 72 | Gaze-evoked nystagmus (HP:0000640) | 2.54532453 |
| 73 | Urinary urgency (HP:0000012) | 2.54252365 |
| 74 | Areflexia of lower limbs (HP:0002522) | 2.53483463 |
| 75 | Pendular nystagmus (HP:0012043) | 2.53036070 |
| 76 | Genetic anticipation (HP:0003743) | 2.52722229 |
| 77 | Decreased circulating renin level (HP:0003351) | 2.51459395 |
| 78 | Abnormality of the renal collecting system (HP:0004742) | 2.50868276 |
| 79 | Peripheral hypomyelination (HP:0007182) | 2.48246445 |
| 80 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.48002511 |
| 81 | Hyperventilation (HP:0002883) | 2.47265183 |
| 82 | Abnormal drinking behavior (HP:0030082) | 2.44154975 |
| 83 | Polydipsia (HP:0001959) | 2.44154975 |
| 84 | Decreased central vision (HP:0007663) | 2.41561294 |
| 85 | Medial flaring of the eyebrow (HP:0010747) | 2.41497923 |
| 86 | Cystic liver disease (HP:0006706) | 2.41174804 |
| 87 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.39145425 |
| 88 | Palpitations (HP:0001962) | 2.37608113 |
| 89 | Short phalanx of the thumb (HP:0009660) | 2.36257760 |
| 90 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.36206875 |
| 91 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.36206875 |
| 92 | Abnormal ciliary motility (HP:0012262) | 2.35325152 |
| 93 | Tubular atrophy (HP:0000092) | 2.32864265 |
| 94 | Retrobulbar optic neuritis (HP:0100654) | 2.31704459 |
| 95 | Optic neuritis (HP:0100653) | 2.31704459 |
| 96 | Ventricular fibrillation (HP:0001663) | 2.31534510 |
| 97 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.23663706 |
| 98 | Amblyopia (HP:0000646) | 2.22541599 |
| 99 | Hyperkalemia (HP:0002153) | 2.21603706 |
| 100 | Increased CSF protein (HP:0002922) | 2.20740280 |
| 101 | Cerebral hemorrhage (HP:0001342) | 2.20450207 |
| 102 | Arthropathy (HP:0003040) | 2.18904386 |
| 103 | Absent thumb (HP:0009777) | 2.17241199 |
| 104 | Facial shape deformation (HP:0011334) | 2.16452898 |
| 105 | Potter facies (HP:0002009) | 2.16452898 |
| 106 | Duplicated collecting system (HP:0000081) | 2.14514508 |
| 107 | Chin dimple (HP:0010751) | 2.14346592 |
| 108 | Abolished electroretinogram (ERG) (HP:0000550) | 2.14236277 |
| 109 | Broad-based gait (HP:0002136) | 2.13284502 |
| 110 | Hypochromic microcytic anemia (HP:0004840) | 2.12846034 |
| 111 | Type II lissencephaly (HP:0007260) | 2.10618648 |
| 112 | Focal motor seizures (HP:0011153) | 2.10425131 |
| 113 | Hypoplastic iliac wings (HP:0002866) | 2.10347247 |
| 114 | Stomach cancer (HP:0012126) | 2.06260382 |
| 115 | Abnormality of magnesium homeostasis (HP:0004921) | 2.04970261 |
| 116 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.04717455 |
| 117 | Protruding tongue (HP:0010808) | 2.04021959 |
| 118 | Abnormality of the nasal septum (HP:0000419) | 2.03963562 |
| 119 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.03379022 |
| 120 | Myositis (HP:0100614) | 2.02788120 |
| 121 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.01998989 |
| 122 | Tachypnea (HP:0002789) | 2.01039804 |
| 123 | Orchitis (HP:0100796) | 2.00843057 |
| 124 | Severe visual impairment (HP:0001141) | 2.00840854 |
| 125 | Limb dystonia (HP:0002451) | 1.99955855 |
| 126 | Muscle stiffness (HP:0003552) | 1.99608852 |
| 127 | Spastic gait (HP:0002064) | 1.99246752 |
| 128 | Gait imbalance (HP:0002141) | 1.98677845 |
| 129 | Congenital hepatic fibrosis (HP:0002612) | 1.98515300 |
| 130 | Decreased muscle mass (HP:0003199) | 1.97448104 |
| 131 | Anencephaly (HP:0002323) | 1.96857766 |
| 132 | Calf muscle hypertrophy (HP:0008981) | 1.96597295 |
| 133 | Axonal loss (HP:0003447) | 1.96045562 |
| 134 | Polyuria (HP:0000103) | 1.95390971 |
| 135 | Absent phalangeal crease (HP:0006109) | 1.94942088 |
| 136 | Male pseudohermaphroditism (HP:0000037) | 1.93683290 |
| 137 | Peripheral demyelination (HP:0011096) | 1.93296466 |
| 138 | Abnormality of the lower motor neuron (HP:0002366) | 1.93017603 |
| 139 | Absent speech (HP:0001344) | 1.92990642 |
| 140 | Rapidly progressive (HP:0003678) | 1.92613458 |
| 141 | Mask-like facies (HP:0000298) | 1.91001383 |
| 142 | Truncal ataxia (HP:0002078) | 1.90442873 |
| 143 | Absence seizures (HP:0002121) | 1.89952480 |
| 144 | Furrowed tongue (HP:0000221) | 1.89929855 |
| 145 | EMG: neuropathic changes (HP:0003445) | 1.89144437 |
| 146 | Toxemia of pregnancy (HP:0100603) | 1.89074567 |
| 147 | Episodic fever (HP:0001954) | 1.88841574 |
| 148 | Exotropia (HP:0000577) | 1.87668351 |
| 149 | Chorioretinal atrophy (HP:0000533) | 1.87563370 |
| 150 | Keratoconus (HP:0000563) | 1.85862706 |
| 151 | Increased corneal curvature (HP:0100692) | 1.85862706 |
| 152 | Overlapping toe (HP:0001845) | 1.85160470 |
| 153 | Abnormality of the parathyroid morphology (HP:0011766) | 1.85086605 |
| 154 | Curly hair (HP:0002212) | 1.82368938 |
| 155 | Down-sloping shoulders (HP:0200021) | 1.81601884 |
| 156 | Clumsiness (HP:0002312) | 1.81413906 |
| 157 | Hypomagnesemia (HP:0002917) | 1.80397939 |
| 158 | Fasciculations (HP:0002380) | 1.80344081 |
| 159 | Spinal canal stenosis (HP:0003416) | 1.79992391 |
| 160 | Anosmia (HP:0000458) | 1.79915657 |
| 161 | Muscle fiber inclusion bodies (HP:0100299) | 1.79366244 |
| 162 | Constricted visual fields (HP:0001133) | 1.79180937 |
| 163 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.78309525 |
| 164 | Chronic sinusitis (HP:0011109) | 1.77760635 |
| 165 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.77561189 |
| 166 | Neonatal onset (HP:0003623) | 1.77357979 |
| 167 | Lower limb muscle weakness (HP:0007340) | 1.76731645 |
| 168 | Congenital primary aphakia (HP:0007707) | 1.76676709 |
| 169 | Sclerocornea (HP:0000647) | 1.76207778 |
| 170 | Popliteal pterygium (HP:0009756) | 1.75781052 |
| 171 | Visual hallucinations (HP:0002367) | 1.75235822 |
| 172 | Stenosis of the external auditory canal (HP:0000402) | 1.75181155 |
| 173 | Neuroblastic tumors (HP:0004376) | 1.74943747 |
| 174 | Peripheral primitive neuroectodermal neoplasm (HP:0030067) | 1.74943747 |
| 175 | Neuroblastoma (HP:0003006) | 1.74943747 |
| 176 | Primitive neuroectodermal tumor (HP:0030065) | 1.74943747 |
| 177 | Abnormality of DNA repair (HP:0003254) | 1.73011217 |
| 178 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.71975137 |
| 179 | Aqueductal stenosis (HP:0002410) | 1.71423219 |
| 180 | Dialeptic seizures (HP:0011146) | 1.70837626 |
| 181 | Tented upper lip vermilion (HP:0010804) | 1.70792443 |
| 182 | Menstrual irregularities (HP:0000858) | 1.70092462 |
| 183 | Chronic otitis media (HP:0000389) | 1.69915851 |
| 184 | Paraplegia (HP:0010550) | 1.69863166 |
| 185 | Hyperparathyroidism (HP:0000843) | 1.69857362 |
| 186 | Ketoacidosis (HP:0001993) | 1.69849481 |
| 187 | Ketosis (HP:0001946) | 1.69817674 |
| 188 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.69323998 |
| 189 | Retinitis pigmentosa (HP:0000510) | 1.69209088 |
| 190 | Abnormal urine output (HP:0012590) | 1.69082225 |
| 191 | Clubbing of toes (HP:0100760) | 1.68143930 |
| 192 | Severe muscular hypotonia (HP:0006829) | 1.66857808 |
| 193 | Frequent falls (HP:0002359) | 1.66679602 |
| 194 | Macroglossia (HP:0000158) | 1.65327079 |
| 195 | Thyroiditis (HP:0100646) | 1.64760149 |
| 196 | Keratitis (HP:0000491) | 1.63903463 |
| 197 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.62341082 |
| 198 | Abnormality of renin-angiotensin system (HP:0000847) | 1.61506148 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK1 | 4.59060114 |
| 2 | LMTK2 | 4.09136231 |
| 3 | KSR2 | 3.71467909 |
| 4 | MAP3K2 | 3.31298112 |
| 5 | MINK1 | 3.21937482 |
| 6 | LIMK1 | 3.17500682 |
| 7 | MAP3K9 | 3.06378752 |
| 8 | MATK | 3.04036152 |
| 9 | MAPKAPK3 | 2.97828565 |
| 10 | NTRK3 | 2.80167402 |
| 11 | TEC | 2.78035208 |
| 12 | ADRBK2 | 2.68054835 |
| 13 | TAOK3 | 2.57856564 |
| 14 | GRK5 | 2.54334360 |
| 15 | OBSCN | 2.38504983 |
| 16 | RET | 2.30434911 |
| 17 | LATS2 | 2.23333016 |
| 18 | RIPK4 | 2.16823824 |
| 19 | MAP3K12 | 2.16347247 |
| 20 | ACVR1B | 2.15389859 |
| 21 | GRK1 | 2.14054018 |
| 22 | EPHA3 | 2.02627981 |
| 23 | ARAF | 1.94746892 |
| 24 | ITK | 1.93924673 |
| 25 | MAP2K1 | 1.87257794 |
| 26 | WNK3 | 1.85797651 |
| 27 | NUAK1 | 1.72279119 |
| 28 | TNK2 | 1.64450336 |
| 29 | YES1 | 1.63233477 |
| 30 | PHKG2 | 1.60711544 |
| 31 | PHKG1 | 1.60711544 |
| 32 | SIK2 | 1.57048253 |
| 33 | BTK | 1.53581270 |
| 34 | RPS6KA2 | 1.46384272 |
| 35 | MAP2K2 | 1.41006317 |
| 36 | SIK3 | 1.37746659 |
| 37 | FER | 1.34776189 |
| 38 | TXK | 1.32604296 |
| 39 | INSRR | 1.30501357 |
| 40 | MAP3K1 | 1.23477392 |
| 41 | MAPKAPK5 | 1.18393431 |
| 42 | MAP3K7 | 1.16802165 |
| 43 | PIM2 | 1.13512990 |
| 44 | FRK | 1.12700283 |
| 45 | MAP2K4 | 1.12561025 |
| 46 | MAP4K2 | 1.12136688 |
| 47 | MAP3K4 | 1.11912746 |
| 48 | PAK6 | 1.10760284 |
| 49 | ZAK | 1.08071881 |
| 50 | WNK1 | 1.07637405 |
| 51 | IRAK1 | 1.06095512 |
| 52 | DAPK2 | 1.05225838 |
| 53 | MARK2 | 1.03114529 |
| 54 | TESK1 | 1.02498421 |
| 55 | IRAK4 | 1.02125892 |
| 56 | SGK494 | 0.98768608 |
| 57 | SGK223 | 0.98768608 |
| 58 | PIK3CG | 0.97580031 |
| 59 | MARK3 | 0.95006096 |
| 60 | NME1 | 0.94922908 |
| 61 | NEK9 | 0.94560067 |
| 62 | RPS6KB2 | 0.93449098 |
| 63 | PRKG2 | 0.93330921 |
| 64 | OXSR1 | 0.90915711 |
| 65 | CAMKK2 | 0.90631078 |
| 66 | SCYL2 | 0.88866218 |
| 67 | ERBB3 | 0.88463166 |
| 68 | CSK | 0.87351581 |
| 69 | PRKAA2 | 0.87311489 |
| 70 | ADRBK1 | 0.86424837 |
| 71 | MUSK | 0.86147118 |
| 72 | GRK6 | 0.84961410 |
| 73 | MAPK13 | 0.84579621 |
| 74 | MARK1 | 0.83702207 |
| 75 | STK11 | 0.83335316 |
| 76 | AKT3 | 0.81146761 |
| 77 | MAP2K7 | 0.79592581 |
| 78 | IKBKB | 0.78928587 |
| 79 | SYK | 0.78521260 |
| 80 | STK24 | 0.76969929 |
| 81 | PRKAA1 | 0.76527142 |
| 82 | CASK | 0.76496852 |
| 83 | FGFR3 | 0.72877225 |
| 84 | TRPM7 | 0.72798591 |
| 85 | PRKCE | 0.72733949 |
| 86 | STK39 | 0.72294346 |
| 87 | EPHB1 | 0.71806334 |
| 88 | SGK2 | 0.71060764 |
| 89 | PRKD2 | 0.70794589 |
| 90 | CDK5 | 0.69261712 |
| 91 | DYRK1B | 0.68908883 |
| 92 | NEK1 | 0.68597598 |
| 93 | PIK3CA | 0.68045994 |
| 94 | PTK2 | 0.67823073 |
| 95 | CHUK | 0.67494702 |
| 96 | IKBKE | 0.66817282 |
| 97 | LYN | 0.65068500 |
| 98 | CAMKK1 | 0.64946469 |
| 99 | EEF2K | 0.64910137 |
| 100 | CSNK1G2 | 0.64210892 |
| 101 | NLK | 0.64097035 |
| 102 | TLK1 | 0.63091772 |
| 103 | WNK4 | 0.62850288 |
| 104 | GRK7 | 0.62204959 |
| 105 | CAMK1D | 0.62140877 |
| 106 | CSNK1G3 | 0.61467535 |
| 107 | CAMK1 | 0.61200417 |
| 108 | SGK3 | 0.59302403 |
| 109 | BLK | 0.58314235 |
| 110 | MAP4K1 | 0.57986839 |
| 111 | ERBB2 | 0.56474964 |
| 112 | CDK14 | 0.56467260 |
| 113 | PKN1 | 0.55553103 |
| 114 | DYRK1A | 0.54669842 |
| 115 | PTK2B | 0.54291662 |
| 116 | HCK | 0.54093902 |
| 117 | SGK1 | 0.52065679 |
| 118 | MAPK12 | 0.52033602 |
| 119 | KSR1 | 0.51373581 |
| 120 | MST4 | 0.50456394 |
| 121 | TYK2 | 0.50067099 |
| 122 | UHMK1 | 0.49562918 |
| 123 | MAP3K11 | 0.48550403 |
| 124 | FGFR4 | 0.48485595 |
| 125 | MAP2K3 | 0.48395160 |
| 126 | TSSK6 | 0.48213939 |
| 127 | PRKCQ | 0.47918460 |
| 128 | LRRK2 | 0.47720725 |
| 129 | PRKCI | 0.45242220 |
| 130 | PRKG1 | 0.43896063 |
| 131 | FGFR2 | 0.43509485 |
| 132 | KIT | 0.42121616 |
| 133 | NTRK2 | 0.40948613 |
| 134 | DYRK3 | 0.40304595 |
| 135 | MAPKAPK2 | 0.38669587 |
| 136 | MAP2K6 | 0.38082770 |
| 137 | PRKCG | 0.37690321 |
| 138 | CAMK4 | 0.37668619 |
| 139 | MAPK15 | 0.37081449 |
| 140 | BMPR1B | 0.35917925 |
| 141 | CAMK2G | 0.35664560 |
| 142 | SRC | 0.35547689 |
| 143 | ERBB4 | 0.35243896 |
| 144 | CAMK2D | 0.34003420 |
| 145 | PINK1 | 0.33140877 |
| 146 | PRKACA | 0.32124750 |
| 147 | ROCK1 | 0.31185546 |
| 148 | CSNK1A1L | 0.31057087 |
| 149 | CAMK2A | 0.30885145 |
| 150 | TAOK1 | 0.30082441 |
| 151 | PDPK1 | 0.30060922 |
| 152 | TRIB3 | 0.29814127 |
| 153 | PRKCZ | 0.28873137 |
| 154 | PDK1 | 0.28864293 |
| 155 | PRKACG | 0.28815798 |
| 156 | CDC42BPA | 0.28679950 |
| 157 | PRKCH | 0.28271147 |
| 158 | PAK3 | 0.26853215 |
| 159 | EPHB2 | 0.26647981 |
| 160 | ROCK2 | 0.26152684 |
| 161 | DYRK2 | 0.25870521 |
| 162 | ZAP70 | 0.25471426 |
| 163 | CDK18 | 0.24975516 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 3.38076510 |
| 2 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 3.33261032 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.07731597 |
| 4 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.66159493 |
| 5 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.63602836 |
| 6 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.46542482 |
| 7 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 2.25697293 |
| 8 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 2.14399519 |
| 9 | Thyroid cancer_Homo sapiens_hsa05216 | 2.12828069 |
| 10 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.10031342 |
| 11 | Phototransduction_Homo sapiens_hsa04744 | 2.08060956 |
| 12 | Taste transduction_Homo sapiens_hsa04742 | 2.03833259 |
| 13 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.96022578 |
| 14 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.87806586 |
| 15 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.84410417 |
| 16 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.81752530 |
| 17 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.79750296 |
| 18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.78183376 |
| 19 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.75314808 |
| 20 | Olfactory transduction_Homo sapiens_hsa04740 | 1.72576764 |
| 21 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.72472770 |
| 22 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.63427334 |
| 23 | Insulin secretion_Homo sapiens_hsa04911 | 1.61779859 |
| 24 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.56170760 |
| 25 | Nicotine addiction_Homo sapiens_hsa05033 | 1.54633535 |
| 26 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.54605103 |
| 27 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.50923970 |
| 28 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.48584213 |
| 29 | ABC transporters_Homo sapiens_hsa02010 | 1.43042820 |
| 30 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.41965279 |
| 31 | Morphine addiction_Homo sapiens_hsa05032 | 1.40857973 |
| 32 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.39542095 |
| 33 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.35868459 |
| 34 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.32720812 |
| 35 | Circadian rhythm_Homo sapiens_hsa04710 | 1.29448254 |
| 36 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.28955243 |
| 37 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.25697259 |
| 38 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.24948663 |
| 39 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.24493086 |
| 40 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.24214565 |
| 41 | Long-term potentiation_Homo sapiens_hsa04720 | 1.22847534 |
| 42 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.22633281 |
| 43 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.19128820 |
| 44 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.18956635 |
| 45 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.18256482 |
| 46 | Glioma_Homo sapiens_hsa05214 | 1.16961770 |
| 47 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.16420486 |
| 48 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.14483236 |
| 49 | Salivary secretion_Homo sapiens_hsa04970 | 1.13750534 |
| 50 | Salmonella infection_Homo sapiens_hsa05132 | 1.08340093 |
| 51 | Gap junction_Homo sapiens_hsa04540 | 1.06442290 |
| 52 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.06406986 |
| 53 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.05605527 |
| 54 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.05341904 |
| 55 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.04152119 |
| 56 | Endometrial cancer_Homo sapiens_hsa05213 | 1.03825548 |
| 57 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.03116520 |
| 58 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.02351460 |
| 59 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.02058701 |
| 60 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.01697040 |
| 61 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.00089165 |
| 62 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.95876333 |
| 63 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.95019324 |
| 64 | Melanoma_Homo sapiens_hsa05218 | 0.94816438 |
| 65 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.94453843 |
| 66 | Circadian entrainment_Homo sapiens_hsa04713 | 0.93484428 |
| 67 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.93319774 |
| 68 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.92733750 |
| 69 | Parkinsons disease_Homo sapiens_hsa05012 | 0.91555434 |
| 70 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.91176043 |
| 71 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.91112051 |
| 72 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.90816269 |
| 73 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.89656769 |
| 74 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.89028329 |
| 75 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.88829470 |
| 76 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.88768405 |
| 77 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.88449316 |
| 78 | Bile secretion_Homo sapiens_hsa04976 | 0.88270537 |
| 79 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.87891498 |
| 80 | Endocytosis_Homo sapiens_hsa04144 | 0.87352298 |
| 81 | Lysine degradation_Homo sapiens_hsa00310 | 0.86752310 |
| 82 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.86653173 |
| 83 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.86474320 |
| 84 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.85449628 |
| 85 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.85378075 |
| 86 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.84496537 |
| 87 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.84162255 |
| 88 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.83650827 |
| 89 | Long-term depression_Homo sapiens_hsa04730 | 0.83330794 |
| 90 | Mineral absorption_Homo sapiens_hsa04978 | 0.82812959 |
| 91 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.82494391 |
| 92 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.78777451 |
| 93 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.78625350 |
| 94 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.78211604 |
| 95 | Phagosome_Homo sapiens_hsa04145 | 0.78169662 |
| 96 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.77885733 |
| 97 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.75741130 |
| 98 | GABAergic synapse_Homo sapiens_hsa04727 | 0.74961665 |
| 99 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.74898305 |
| 100 | Alzheimers disease_Homo sapiens_hsa05010 | 0.74440988 |
| 101 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.74401008 |
| 102 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.74208736 |
| 103 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.72265941 |
| 104 | Insulin resistance_Homo sapiens_hsa04931 | 0.70664408 |
| 105 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.69624318 |
| 106 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.68878794 |
| 107 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.67764478 |
| 108 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.66711501 |
| 109 | Melanogenesis_Homo sapiens_hsa04916 | 0.66486172 |
| 110 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.65895588 |
| 111 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.65462809 |
| 112 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.65333696 |
| 113 | Histidine metabolism_Homo sapiens_hsa00340 | 0.65154061 |
| 114 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.64471817 |
| 115 | Renin secretion_Homo sapiens_hsa04924 | 0.64364309 |
| 116 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.63080638 |
| 117 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.62452863 |
| 118 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.61578396 |
| 119 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.60717021 |
| 120 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.58435925 |
| 121 | Retinol metabolism_Homo sapiens_hsa00830 | 0.57840919 |
| 122 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.56703280 |
| 123 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.56122709 |
| 124 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.55319737 |
| 125 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55147998 |
| 126 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.54866823 |
| 127 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.54779634 |
| 128 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.54228670 |
| 129 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.53903144 |
| 130 | Axon guidance_Homo sapiens_hsa04360 | 0.53503747 |
| 131 | Peroxisome_Homo sapiens_hsa04146 | 0.53035275 |
| 132 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.52859806 |
| 133 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.51947322 |
| 134 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.50828883 |
| 135 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.50683889 |
| 136 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.50162582 |
| 137 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.49952880 |
| 138 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.49776828 |
| 139 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.49471657 |
| 140 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.49091448 |
| 141 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47931880 |
| 142 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.47587666 |
| 143 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.46995425 |
| 144 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.46750591 |
| 145 | Cocaine addiction_Homo sapiens_hsa05030 | 0.46419774 |
| 146 | Measles_Homo sapiens_hsa05162 | 0.46179957 |
| 147 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.45519398 |
| 148 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44169953 |
| 149 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.43906121 |
| 150 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.43237339 |
| 151 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.43179015 |
| 152 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.41862373 |
| 153 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.40410714 |
| 154 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.40036708 |
| 155 | Platelet activation_Homo sapiens_hsa04611 | 0.39736606 |
| 156 | Bladder cancer_Homo sapiens_hsa05219 | 0.39572887 |
| 157 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.39491033 |
| 158 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.38659417 |
| 159 | Prion diseases_Homo sapiens_hsa05020 | 0.36939944 |
| 160 | Shigellosis_Homo sapiens_hsa05131 | 0.36646832 |

